Successful treatment with rituximab of one patient with CANOMAD neuropathy
- PMID: 19960199
- DOI: 10.1007/s00415-009-5412-z
Successful treatment with rituximab of one patient with CANOMAD neuropathy
Abstract
We report a successful treatment with rituximab in a patient with CANOMAD neuropathy resistant to previous therapy. The titers of anti-disialosyl antibodies were decreased 3 months after the beginning of the treatment and the sensory ataxia clearly improved after 9 months of therapy.
Similar articles
-
Successful treatment of CANOMAD with IVIg and rituximab.J Neurol. 2013 Apr;260(4):1168-70. doi: 10.1007/s00415-013-6867-5. Epub 2013 Feb 12. J Neurol. 2013. PMID: 23400502 No abstract available.
-
[Identification and characterization of a monoclonal IgM reacting with disialylated gangliosides recognizing the CANOMAD syndrome].Ann Biol Clin (Paris). 2011 Jul-Aug;69(4):476-80. doi: 10.1684/abc.2011.0603. Ann Biol Clin (Paris). 2011. PMID: 21896416 French.
-
Chronic ataxic neuropathy mimicking dorsal midbrain syndrome.J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1276-7. doi: 10.1136/jnnp.2007.120444. Epub 2007 May 15. J Neurol Neurosurg Psychiatry. 2007. PMID: 17504882 Free PMC article.
-
The role of rituximab in adults with warm antibody autoimmune hemolytic anemia.Blood. 2015 May 21;125(21):3223-9. doi: 10.1182/blood-2015-01-588392. Epub 2015 Mar 31. Blood. 2015. PMID: 25827833 Review.
-
Treatment with rituximab in benign and malignant hematologic disorders in children.J Pediatr. 2007 Apr;150(4):338-44, 344.e1. doi: 10.1016/j.jpeds.2006.12.038. J Pediatr. 2007. PMID: 17382107 Free PMC article. Review. No abstract available.
Cited by
-
Paraproteinemic neuropathy: a practical review.BMC Neurol. 2016 Jan 28;16:13. doi: 10.1186/s12883-016-0532-4. BMC Neurol. 2016. PMID: 26821540 Free PMC article. Review.
-
Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies.Ann Transl Med. 2018 Sep;6(17):337. doi: 10.21037/atm.2018.07.34. Ann Transl Med. 2018. PMID: 30306076 Free PMC article. Review.
-
An update on monoclonal gammopathy and neuropathy.Curr Neurol Neurosci Rep. 2012 Feb;12(1):102-10. doi: 10.1007/s11910-011-0237-4. Curr Neurol Neurosci Rep. 2012. PMID: 22090258 Review.
-
Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment.Front Immunol. 2022 Nov 23;13:1045002. doi: 10.3389/fimmu.2022.1045002. eCollection 2022. Front Immunol. 2022. PMID: 36505449 Free PMC article. Review.
-
Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing.Mediterr J Rheumatol. 2020 Mar 31;31(1):10-18. doi: 10.31138/mjr.31.1.10. eCollection 2020 Mar. Mediterr J Rheumatol. 2020. PMID: 32411930 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources